Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
        
        Real-World Data
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        Order a Renasight Kit
        Contact Us
        Pricing and Billing Information
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Order a Renasight Kit
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        Altera
        Empower
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        Renasight
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients – USA)
        
        Schedule Blood Draw (Existing Patients – Canada)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Signatera
        Signatera Publications
        Altera
        Empower
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        BESPOKE CRC
        
        BESPOKE IO
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        Prospera
        Renasight
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        Natera Academy Provider Education Hub
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Signatera
MRD Testing in NSCLC to Personalize Patient Care

MRD Testing in NSCLC to Personalize Patient Care

Published Date March 5, 2025

Fill form to unlock content

Loading, please wait

Error - something went wrong!

Please fill out form to access this item.

Thank you!

Previous Video

Jason's Patient Testimonial
Next Video

Unlocking new uses for old drugs

a revolution in precision oncology using evidence-based MRD testing

MRD Testing in NSCLC to Personalize Patient Care

Signatera Sample Collection

New Data Review Can treating molecular residual disease (MRD) in colorectal cancer improve outcomes

A Rare Cancer, A Powerful Tool: What the New Guidelines Mean for Merkel Cell Carcinoma Patients

How MRD Testing Supports Colorectal Cancer Patients: Jason’s Story and the Importance of Regular Monitoring

Jason's Patient Testimonial

Unlocking new uses for old drugs

Medicare Expands Coverage of Signatera for Patients with Lung Cancer

How to Use Natera’s Patient Portal to Manage Your Cancer Care

What Is MRD Testing and How Can It Help Monitor Cancer Recurrence?

New data: Optimizing breast cancer care and drug development with molecular residual disease testing

Signatera for Colorectal Liver Metastases

Natera at SABCS 2024: What It Means for Breast Cancer Survivors

How to Talk to Your Doctor About Signatera for Lung Cancer

The Tipping Point: How clinically validated MRD testing is transforming patient management in colorectal cancer

Utilization of Circulating Tumor DNA in the Surveillance Setting

Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors

Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer

Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors

Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma

Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma